TriSalus Life Sciences, Inc.
TLSI· Nasdaq
TriSalus Life Sciences, Inc.
- Last sale
- Oct 2, 2026 · +3.85%
- Market cap
- $266.00M
- 61.57M shares
- Filings
- 489
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $45,151,000 | reported | |
| FY 2024 | 2024-12-31 | $29,431,000 | reported | |
| FY 2023 | 2023-12-31 | $18,511,000 | reported | |
| FY 2022 | 2022-12-31 | $12,398,000 | reported |
TriSalus Life Sciences, Inc. · CIK 1826667 · Engraved from SEC EDGAR
